41 related articles for article (PubMed ID: 10391684)
21. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
22. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
23. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
[TBL] [Abstract][Full Text] [Related]
24. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
25. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
[TBL] [Abstract][Full Text] [Related]
26. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer.
Biggs PJ; Warren W; Venitt S; Stratton MR
Mutagenesis; 1993 Jul; 8(4):275-83. PubMed ID: 8377645
[TBL] [Abstract][Full Text] [Related]
27. The soluble p51 protein in cancer diagnosis, prevention and therapy.
Zusman I
In Vivo; 2005; 19(3):591-8. PubMed ID: 15875781
[TBL] [Abstract][Full Text] [Related]
28. Molecular approaches to lung cancer evaluation.
Niklinski J; Hirsch FR
Lung Cancer; 2002 Dec; 38 Suppl 3():S9-17. PubMed ID: 12468138
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
30. p53 family genes: structural comparison, expression and mutation.
Ikawa S; Nakagawara A; Ikawa Y
Cell Death Differ; 1999 Dec; 6(12):1154-61. PubMed ID: 10637430
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of p53 tumor suppressor in yeast.
Smardová J; Smarda J; Koptíková J
Differentiation; 2005 Jul; 73(6):261-77. PubMed ID: 16138827
[TBL] [Abstract][Full Text] [Related]
32. [Oncogenes and tumor suppressor genes of human breast cancer].
Takita K; Sato T; Nakamura Y
Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):305-13. PubMed ID: 8098157
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]